Insider Transactions in Q2 2022 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Laura Clague Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,914
+28.28%
|
-
|
|
Jun 15
2022
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Direct |
30,914
+39.8%
|
-
|
|
Jun 15
2022
|
Carlos V Paya Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,914
+23.53%
|
-
|
|
Jun 15
2022
|
Frank Witney |
BUY
Grant, award, or other acquisition
|
Direct |
30,914
+39.8%
|
-
|
|
Jun 15
2022
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
30,914
+39.8%
|
-
|
|
Jun 15
2022
|
Gerhard F Burbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,914
+24.2%
|
-
|
|
Jun 15
2022
|
Bill Colston Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,914
+34.27%
|
-
|
|
Jun 13
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.94%
|
$100,000
$1.7 P/Share
|
|
Jun 03
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+2.34%
|
$250,000
$1.98 P/Share
|
|
Jun 02
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+1.93%
|
$200,000
$1.92 P/Share
|
|
May 31
2022
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,341
+3.22%
|
$3,341
$1.61 P/Share
|
|
May 20
2022
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,361
-8.15%
|
$28,722
$2.05 P/Share
|
|
May 20
2022
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,901
+4.72%
|
-
|
|
May 20
2022
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
14,161
-12.72%
|
-
|
|
May 20
2022
|
Nicholas Khadder SVP, Gen. Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
28,909
+8.5%
|
-
|
|
May 20
2022
|
Bradley Allen Kreger SVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
14,431
-10.8%
|
$28,862
$2.05 P/Share
|
|
May 20
2022
|
Bradley Allen Kreger SVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
42,280
+6.25%
|
-
|
|
May 10
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,000
+0.25%
|
$50,000
$2.52 P/Share
|
|
May 06
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
463,350
+4.45%
|
$926,700
$2.9 P/Share
|
|
May 02
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
125,000
+1.3%
|
$250,000
$2.81 P/Share
|
|
Apr 29
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
247,400
+2.58%
|
$494,800
$2.66 P/Share
|
|
Apr 28
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
27,600
+0.3%
|
$55,200
$2.4 P/Share
|
|
Apr 12
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+0.55%
|
$150,000
$3.6 P/Share
|
|
Apr 11
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
145,000
+1.58%
|
$435,000
$3.87 P/Share
|
|
Apr 08
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+2.2%
|
$600,000
$3.76 P/Share
|
|
Apr 07
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+2.25%
|
$600,000
$3.88 P/Share
|
|
Apr 06
2022
|
Caligan Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
109,573
+1.27%
|
$328,719
$3.6 P/Share
|
|
Apr 04
2022
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Direct |
15,852
+50.0%
|
-
|
|
Apr 04
2022
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
15,852
+50.0%
|
-
|
|
Apr 04
2022
|
Frank Witney |
BUY
Grant, award, or other acquisition
|
Direct |
15,852
+50.0%
|
-
|
|
Apr 01
2022
|
Nicolas Barthelemy Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
20,993
+9.33%
|
$62,979
$3.74 P/Share
|